Form 8-K RIGEL PHARMACEUTICALS For: Apr 16

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Form 8-K RIGEL PHARMACEUTICALS For: Apr 16

Rigel Pharmaceuticals regains rights as Lilly terminates license deal

April 21, 2026 4:22 PM EDT

Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) received notice that Eli Lilly and Company will terminate their license and collaboration agreement, effective June 15, 2026, according to a company statement.

Lilly notified Rigel on April 16, 2026 of its decision to terminate the February 2021 agreement in its entirety. The... More